Bausch + Lomb
BLCO • NYSE
Bausch + Lomb is a medical - instruments & supplies company in the healthcare sector trading on NYSE, led by CEO Brenton L. Saunders, with a market cap of $5.4B.
CEOBrenton L. Saunders
Next Earnings
Upcoming earnings announcement for Bausch + Lomb
Date
Wednesday, April 29, 2026 (in 4 weeks)
Timing
Before Market Open (6:58 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.05
Revenue Estimate
$1.2B
Earnings History
Past 12 earnings reports for Bausch + Lomb
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 18, 2026 | Q4 2025 | $0.32Est: $0.35 | -8.6% | $1.4BEst: $1.4B | +1.6% |  10-K |
| Oct 29, 2025 | Q3 2025 | $0.18Est: $0.16 | +12.5% | $1.3BEst: $1.3B | +0.2% | 10-Q |
| Jul 30, 2025 | Q2 2025 | $0.07Est: $0.07 | 0.0% | $1.3BEst: $1.3B | +2.0% | 10-Q |
| Apr 30, 2025 | Q1 2025 | -$0.07Est: $0.02 | -450.0% | $1.1BEst: $1.2B | -1.1% | 10-Q |
| Feb 19, 2025 | Q4 2024 | $0.25Est: $0.24 | +4.2% | $1.3BEst: $1.3B | +2.4% | 10-K |
| Oct 30, 2024 | Q3 2024 | $0.17Est: $0.22 | -22.7% | $1.2BEst: $1.6B | -27.1% | 10-Q |
| Jul 31, 2024 | Q2 2024 | $0.13Est: $0.17 | -23.5% | $1.2BEst: $1.6B | -24.0% | 10-Q |
| May 1, 2024 | Q1 2024 | $0.07Est: $0.07 | 0.0% | $1.1BEst: $1.5B | -24.2% | 10-Q |
| Feb 21, 2024 | Q4 2023 | $0.24Est: $0.17 | +41.2% | $1.2BEst: $1.0B | +15.3% | 10-K |
| Nov 1, 2023 | Q3 2023 | $0.22Est: $0.26 | -15.4% | $1.0BEst: $1.4B | -26.0% | — |
| Aug 2, 2023 | Q2 2023 | $0.18Est: $0.18 | 0.0% | $1.0BEst: $1.3B | -18.5% | 10-Q |
| May 3, 2023 | Q1 2023 | $0.10Est: $0.14 | -28.6% | $931.0MEst: $1.2B | -23.7% | — |